New England Journal of Medicine Publishes Results of Phase III FLAURA Trial in the 1st-Line Treatment of EGFR-mutated Non-small Cell Lung Cancer
CAMBRIDGE, England--(BUSINESS WIRE)--AstraZeneca today announced that the New England Journal of Medicine has published the positive results from the Phase III FLAURA trial which provide ......